All In Biotech

Drug Trial Radar · NCT05278156

Efficacy, Safety and Pharmacokinetics Study of CPL500036 (PDE10A Inhibitor) in Patients With Schizophrenia

Phase II, Double Blind, Randomized, Placebo Controlled, Parallel Group, Trial to Explore Efficacy, Safety and Pharmacokinetics of CPL500036 (PDE10A Inhibitor) in Patients With an Acute Exacerbation of Schizophrenia

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 189 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

189

Actual

Start

May 19, 2021

Primary completion

Jun 5, 2024

Study completion Jun 19, 2024

Sponsor

Lead sponsor
Celon Pharma SAIndustry
Sponsor type
Industry
Collaborators
National Center for Research and Development, Poland
First posted
Mar 14, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine the efficacy, safety, tolerability and pharmacokinetics (PK) properties of CPL500036 compound (PDE10a inhibitor) in patients with an acute exacerbation of schizophrenia after 28 days of administration..

Conditions

  • Schizophrenia

Interventions

  • CPL500036 - low doseDrug

    CPL500036 is to be oral administered. Each patient is to take 2 capsules with active substance and 2 capsules of placebo daily.

  • CPL500036 - high doseDrug

    CPL500036 is to be oral administered. Each patient is to take 4 capsules with active substance daily.

  • PlaceboDrug

    Placebo is to be oral administered. Each patient is to take 4 capsules of placebo daily.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in PANSS Positive Subscale at Week 4.Time frame: Day -1, Week 4

Locations

16 sites in 3 countries. Site status is shown where the registry gives one.

  • Department of Psychiatry and Psychotheraapy of Semmelweis University

    Budapest, Hungary

  • Semmelweis University, Faculty of Medicine, Department of Psychiatry and Psychotherapy

    Budapest, Hungary

  • Department of Psychiatry, Mental hygiene and Addictology of Petz Aladár County Teaching Hospital

    Győr, Hungary

  • Bács-Kiskun County Teaching Hospital Kalocsa Holy Cross Hospital

    Kalocsa, Hungary

  • Psychiatry Department of Tolna County Balassa Janos Hospital

    Szekszárd, Hungary

  • Uniwersytecki Szpital Kliniczny

    Bialystok, Poland

  • Wojewódzki Szpital dla Nerwowo i Psychicznie Chorych

    Bolesławiec, Poland

  • Samodzielny Publiczny Psychiatryczny Zakład Opieki Zdrowotnej

    Choroszcz, Poland

  • Wojewódzki Szpital dla Psychicznie i Nerwowo Chorych

    Gmina Świecie, Poland

  • Ivano-Frankivsk National Medical University, Department of Psychiatry, Narcology and Medical Psychology

    Ivano-Frankivsk, Ukraine

  • Communal non-profit enterprise "Clinical Hospital "PSYCHIATRY"" of the executive body of the Kyiv City Council (Kyiv City State Administration), Center for Primary Psychotic Episode and Modern Treatment Methods.

    Kyiv, Ukraine

  • Communal non-commercial enterprise of the Kyiv Regional Council "Regional Psychiatric-Narcological Medical Association", women's department No. 2, men's department No. 10.

    Kyiv, Ukraine

  • Communal non-commercial enterprise of the Lviv Regional Council "Lviv Regional Clinical Psychoneurological Dispensary",

    Lviv, Ukraine

  • Communal non- commercial enterprise of Lviv Regional Council "Lviv Regional Clinical Psychiatric Hospital",

    Lviv, Ukraine

  • Ternopil National Medical University named after I.Y. Gorbachevskiy of the Ministry of Health of Ukraine, Department of Psychiatry, Narcology and Medical Psychology

    Ternopil, Ukraine

  • Vinnytsia National Medical University named after M.I. Pirogov, Department of Psychiatry, Narcology and Psychotherapy with a course of postgraduate education

    Vinnytsia, Ukraine

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.